PULSE BIOSCIENCES, INC. current report, 25 May 2023

Pulse Biosciences, Inc. - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Pulse Biosciences, Inc. on May 30, 2023, regarding events occurring on May 25, 2023. The report details the outcomes of the Company's 2023 Annual Meeting of Stockholders, which was conducted as a virtual meeting via live audio webcast.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.

Material Changes and Corporate Actions

  • Director Departure: Director Mitchell E. Levinson did not stand for reelection at the Annual Meeting. He continues to serve as the Company's Chief Strategy Officer. The Company stated this decision was not attributable to any disagreement regarding operations, policies, or practices.
  • Election of Directors: Six director nominees were elected to serve until the 2024 Annual Meeting. All nominees received significant majority support, with "For" votes ranging from approximately 22.3 million to 23.3 million shares.
  • Accounting Firm Ratification: Stockholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the results of the stockholder vote and the status of the departing director.

Key Facts for Investor Verification

  • Verify the continued role of Mitchell E. Levinson as Chief Strategy Officer following his departure from the Board of Directors.
  • Confirm the composition of the Board of Directors for the 2023-2024 term based on the election results.
  • Note the high level of broker non-votes (8,561,105 shares) recorded for the director elections, which may indicate significant shares held in street name without voting instructions.
  • Review the Company's subsequent financial filings (e.g., 10-Q or 10-K) for actual financial performance data, as this 8-K contains none.